Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02324153
Other study ID # IRB00097232
Secondary ID 1R21AG050850-01A
Status Completed
Phase Phase 2
First received
Last updated
Start date March 24, 2017
Est. completion date June 26, 2019

Study information

Verified date June 2020
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial focuses on a Phase II randomized masked clinical trial testing the effectiveness and safety of peri-operative administration of ramelteon, a melatonin agonist in the prevention of postoperative delirium.


Description:

This trial will randomize older aged patients undergoing general or regional anesthesia for orthopedic surgical procedures to three perioperative doses of a melatonin agonist, ramelteon, and placebo in a masked double blind fashion. The primary outcomes are 1) the incidence of post-operative delirium in the recovery period in the Postoperative Anesthesia Care Unit and on post-operative days 1 and 2 following surgery, and 2) the safety of ramelteon as documented by the presence of adverse events in the follow-up period.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date June 26, 2019
Est. primary completion date June 26, 2019
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility - Planned orthopedic surgery under general or regional anesthesia and post-operative inpatient stay

- 65 years of age or older

- Mini-mental Status Exam (MMSE) score of 15 or greater prior to surgery;

- Ability to understand, speak, read and write English.

Exclusion Criteria:

- Delirium diagnosis on the Confusion Assessment Method instrument at baseline

- Is unable to give informed consent due to cognitive impairment and a suitable legally authorized representative (LAR) cannot be identified

- Declines participation

- Current medications that include:

1. ramelteon

2. melatonin

3. fluvoxamine

4. rifampin

5. ketoconazole

6. fluconazole

- History of ramelteon or riboflavin intolerance

- Heavy daily alcohol intake by medical record or history

- Current moderate to severe liver failure (as defined by Charlson criteria

- Evidence of Systemic Inflammatory Response Syndrome (SIRS) as measured by > 2 criteria8)

- Presence of a condition that in the opinion of the PI compromises patient safety or data quality if enrolled in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ramelteon
1 pre-operative and 2 nightly postoperative doses of Ramelteon/placebo will be administered
Microcrystalline Cellulose
Placebo Comparator
Riboflavin 100 mg
Riboflavin will be added to both placebo and active intervention capsules in order to track adherence to dose while taken as an outpatient (i.e. only the first preoperative dose)

Locations

Country Name City State
United States Johns Hopkins Bayview Medical Center Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
Johns Hopkins University National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Delirium During Two Days Following Surgery Delirium DSM 5 based criteria informed by standardized history gathering, examination, cognitive evaluation using cognitive tests, informant interview, and medical record review) measured during Post-operative Day 1 and/or Day 2 Up to Post Operative Day 2
Primary Number of Participants With Delirium in the Post Anesthesia Care Unit (PACU) Delirium (DSM 5 based criteria informed by standardized history gathering, examination, cognitive evaluation using cognitive tests, informant interview, and medical record review) measured once recovered from anesthesia. Post Operative Day 0: Post Anesthesia Care Unit Following Recovery from Anesthesia
Secondary Delirium Rating Scale - Revised- 98 (DRS-R98) in Delirious Patients Measure Description: Delirium Rating Scale-Revised-98 (Severity items are rated on a scale of 0-3 and diagnostic items are rated on a scale of 0-2 or 0-3. The minimum score is 0. The maximum possible score for severity items is 39, while the maximum total score is 46. Higher scores indicate more severe delirium; score of 0 indicates no delirium.) Means and Standard Deviations were calculated from the maximum DRS-R98 score documented on Postoperative Day 1 and Day 2 for each participant who became delirious within each treatment arm. Postoperative Day 1 and Day 2
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT05891873 - Delirium in the (Neuro)Intensive/Critical Care in the Adult and Paediatric Czech Populations
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06194474 - Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
Completed NCT03095417 - Improving the Recovery and Outcome Every Day After the ICU N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Terminated NCT03337282 - Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
Not yet recruiting NCT04846023 - Pediatric Delirium Screening in the PICU Via EEG N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Withdrawn NCT02673450 - PER3 Clock Gene Polymorphism, Clock Gene Expression and Delirium in the Intensive Care Unit.
Recruiting NCT03256500 - Transcranial Direct Current Stimulation for the Treatment of Delirium N/A
Completed NCT02890927 - Geriatric-CO-mAnagement for Cardiology Patients in the Hospital N/A
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Recruiting NCT03165539 - Cerebral Oxygen Desaturation and Post-Operative Delirium in Thoracic Surgical Patients
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Completed NCT02518646 - DElirium prediCtIon in the intenSIve Care Unit: Head to Head comparisON of Two Delirium Prediction Models N/A
Recruiting NCT02305589 - The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium N/A
Completed NCT02628925 - Nu-DESC DK: The Danish Version of the Nursing Delirium Screening Scale N/A